GENSCI098
Clinical trials for GENSCI098 explained in plain language.
Never miss a new study
Get alerted when new GENSCI098 trials appear
Sign up with your email to follow new studies for GENSCI098, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection aims to tame overactive thyroid
Disease control Recruiting nowThis early-stage study tests a single injection of a new drug called GenSci098 in 24 adults with Graves' disease, a condition where the thyroid is overactive. The main goal is to see if the drug is safe and what side effects it might cause. Participants must have stopped other th…
Matched conditions: GENSCI098
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New injection for thyroid eye disease enters first human safety study
Disease control Recruiting nowThis early-stage study tests the safety of a new drug called GenSci098 in 76 adults with active thyroid eye disease (TED). Participants receive one or more injections under the skin, and researchers monitor for side effects and how the drug moves through the body. The goal is to …
Matched conditions: GENSCI098
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 08, 2026 12:00 UTC